MAPT and Alzheimer disease: However, younger age at symptom onset has been conversely found to be associated with accelerated tau accumulation (Smith et al, 2020), neurodegeneration (Moller et al, 2013), cognitive decline (van der Vlies et al, 2009) and higher rates of mortality in AD (Koedam et al, 2008).